{"id":"W4224284079","doi":"10.1101/2022.04.18.22271936","title":"Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Moderna","keywords":"Seroconversion; Medicine; Placebo; Vaccination; Randomized controlled trial; Clinical trial; Internal medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Vaccine trial; Vaccine efficacy; Antibody; Immunology; Coronavirus disease 2019 (COVID-19); Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009525173,0.0005819924,0.001744841,0.0006958283,0.0003789455,0.0001035615,0.001427857,0.0005987937,0.00004752908],"category_scores_gemma":[0.01171706,0.0003672523,0.001748276,0.001416363,0.0002843653,0.00009088044,0.001628547,0.003883873,0.00002283737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000317098,"about_ca_system_score_gemma":0.002126242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001516296,"about_ca_topic_score_gemma":0.0003860425,"domain_scores_codex":[0.9917117,0.002587961,0.00200498,0.001161181,0.001841509,0.0006926446],"domain_scores_gemma":[0.9942278,0.002407117,0.0007816977,0.002342573,0.0001601335,0.00008062661],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02558544,0.005435025,0.9254657,0.0007329058,0.0007162574,0.0005712963,0.001795782,0.00002574993,0.0350671,0.00007118425,0.002454847,0.002078714],"study_design_scores_gemma":[0.3035108,0.004036986,0.3879689,0.0008403669,0.001717449,0.0001166755,0.0005187073,0.00101716,0.06587505,0.001022585,0.2321939,0.001181393],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868441,0.0004661307,0.0000729186,0.003472504,0.003683871,0.004410007,0.00003414426,0.0001290696,0.0008872722],"genre_scores_gemma":[0.9758105,0.0001507057,0.0000335899,0.02262378,0.001002372,0.0002518263,0.00002964935,0.00008100988,0.00001656989],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5374969,"threshold_uncertainty_score":0.9998779,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2155185449195084,"score_gpt":0.4967634561241518,"score_spread":0.2812449112046435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}